New active leads for tuberculosis booster drugs by structure-based drug discovery
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New active leads for tuberculosis booster drugs by structure-based drug discovery
Authors
Keywords
-
Journal
ORGANIC & BIOMOLECULAR CHEMISTRY
Volume 15, Issue 48, Pages 10245-10255
Publisher
Royal Society of Chemistry (RSC)
Online
2017-11-02
DOI
10.1039/c7ob00910k
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reversion of antibiotic resistance inMycobacterium tuberculosisby spiroisoxazoline SMARt-420
- (2017) Nicolas Blondiaux et al. SCIENCE
- Protein Binding Pocket Dynamics
- (2016) Antonia Stank et al. ACCOUNTS OF CHEMICAL RESEARCH
- A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters
- (2016) Petar O. Nikiforov et al. ORGANIC & BIOMOLECULAR CHEMISTRY
- Tuberculosis elimination in the post Millennium Development Goals era
- (2015) Christian Wejse INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Diamond: shedding light on structure-based drug discovery
- (2015) D. G. Brown et al. PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES
- Protein–ligand interactions investigated by thermal shift assays (TSA) and dual polarization interferometry (DPI)
- (2015) Morten K. Grøftehauge et al. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY
- The Protein Data Bank archive as an open data resource
- (2014) Helen M. Berman et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Ligand Efficiency Driven Design of New Inhibitors of Mycobacterium tuberculosis Transcriptional Repressor EthR Using Fragment Growing, Merging, and Linking Approaches
- (2014) Baptiste Villemagne et al. JOURNAL OF MEDICINAL CHEMISTRY
- New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects
- (2014) Alimuddin I Zumla et al. LANCET INFECTIOUS DISEASES
- Structural and docking studies of potent ethionamide boosters
- (2013) Natalie J. Tatum et al. ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS
- A structure-guided fragment-based approach for the discovery of allosteric inhibitors targeting the lipophilic binding site of transcription factor EthR
- (2013) Sachin Surade et al. BIOCHEMICAL JOURNAL
- KNIME-CDK: Workflow-driven cheminformatics
- (2013) Stephan Beisken et al. BMC BIOINFORMATICS
- The underling mechanism of bacterial TetR/AcrR family transcriptional repressors
- (2013) Wanyan Deng et al. CELLULAR SIGNALLING
- Tuberculosis: The drug development pipeline at a glance
- (2012) Baptiste Villemagne et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- Validating and Understanding Ring Conformations Using Small Molecule Crystallographic Data
- (2012) Simon J. Cottrell et al. Journal of Chemical Information and Modeling
- Potential and Limitations of Ensemble Docking
- (2012) Oliver Korb et al. Journal of Chemical Information and Modeling
- ZINC: A Free Tool to Discover Chemistry for Biology
- (2012) John J. Irwin et al. Journal of Chemical Information and Modeling
- Pose prediction and virtual screening performance of GOLD scoring functions in a standardized test
- (2012) John W. Liebeschuetz et al. JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN
- Discovery of Novel N-Phenylphenoxyacetamide Derivatives as EthR Inhibitors and Ethionamide Boosters by Combining High-Throughput Screening and Synthesis
- (2012) Marion Flipo et al. JOURNAL OF MEDICINAL CHEMISTRY
- New tuberculosis drugs on the horizon
- (2011) Stewart T Cole et al. CURRENT OPINION IN MICROBIOLOGY
- Virtual Decoy Sets for Molecular Docking Benchmarks
- (2011) Izhar Wallach et al. Journal of Chemical Information and Modeling
- Ethionamide Boosters: Synthesis, Biological Activity, and Structure−Activity Relationships of a Series of 1,2,4-Oxadiazole EthR Inhibitors
- (2011) Marion Flipo et al. JOURNAL OF MEDICINAL CHEMISTRY
- Ethionamide Boosters. 2. Combining Bioisosteric Replacement and Structure-Based Drug Design To Solve Pharmacokinetic Issues in a Series of Potent 1,2,4-Oxadiazole EthR Inhibitors
- (2011) Marion Flipo et al. JOURNAL OF MEDICINAL CHEMISTRY
- The TB Structural Genomics Consortium: A decade of progress
- (2011) Nicholas Chim et al. TUBERCULOSIS
- Exploring Drug Target Flexibility Usingin SituClick Chemistry: Application to a Mycobacterial Transcriptional Regulator
- (2010) Nicolas Willand et al. ACS Chemical Biology
- Ensemble Docking into Multiple Crystallographically Derived Protein Structures: An Evaluation Based on the Statistical Analysis of Enrichments
- (2010) Ian R. Craig et al. Journal of Chemical Information and Modeling
- New Substructure Filters for Removal of Pan Assay Interference Compounds (PAINS) from Screening Libraries and for Their Exclusion in Bioassays
- (2010) Jonathan B. Baell et al. JOURNAL OF MEDICINAL CHEMISTRY
- Best drug treatment for multidrug-resistant and extensively drug-resistant tuberculosis
- (2010) José A Caminero et al. LANCET INFECTIOUS DISEASES
- Emergence of New Forms of Totally Drug-Resistant Tuberculosis Bacilli
- (2009) Ali Akbar Velayati et al. CHEST
- Synthetic EthR inhibitors boost antituberculous activity of ethionamide
- (2009) Nicolas Willand et al. NATURE MEDICINE
- Extensively drug-resistant tuberculosis: current challenges and threats
- (2008) Amita Jain et al. FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started